Treatment of recurrent dermatofibrosarcoma protuberans with imatinib mesylate, followed by Mohs micrographic surgery.
Wright
Tina I
TI
Division of Dermatology, Washington University, St Louis, Missouri, USA. Tinawright7@yahoo.com
Petersen
Jeffrey E
JE
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001549:Benzamides; D018223:Dermatofibrosarcoma / Q000628:therapy*; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D015580:Mohs Surgery; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D012535:Scalp; D012878:Skin Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate